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SUMMARY – We report a fi rst case of refractory several-hour sinus bradycardia, a rare but  already 
described side eff ect of intramuscular administration of carboprost tromethamine to induce abortion 
for medical indication in a patient without cardiovascular and other diseases. After administration of 
atropine sulfate 3x0.5 mg intravenously without eff ect, the patient‘s sinus rhythm spontaneously 
 normalized as carboprost was eliminated from the body (it has a 3-hour half-life). It is reasonable to 
believe that the specifi c prostaglandin underlay the etiology of bradycardia.
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Introduction
Th e most common drugs in use for the induction 
of abortion and labor, as well as for curative obstetric 
hemorrhage are misoprostol, gemeprost, sulprostone, 
dinoprost and carboprost tromethamine. Th ese drugs 
can be used either intravenously, intramuscularly, per 
os, vaginally or rectally. Carboprost is a synthetic pros-
taglandin analogue of PGF2 that causes myometrial 
contractions by binding to the prostaglandin E2 re-
ceptor. Th e known side eff ects of exogenous prosta-
glandins are irritability, nausea, vomiting, diarrhea, 
coughing, dyspnea, asthma, hypertension, fl ushing, 
and pyrexia. Contraindications include obstructive 
lung disease and clinically relevant infl ammatory dis-
ease. Cardiovascular side eff ects, albeit rare, mainly oc-
cur alongside cardiovascular collapse1-3.
We report a fi rst case of refractory several-hour si-
nus bradycardia, a rare but already described side eff ect 
of intramuscular administration of carboprost to in-
duce abortion with medical indication.
Case Report
A 32-year-old pregnant woman was hospitalized at 
Department of Obstetrics because of preterm prema-
ture rupture of membranes (PPROM) with anhy-
dramnios and intrauterine fetal death in 20th week of 
gestation. Obstetric history revealed two pregnancies 
with two term births with normal neurocognitive de-
velopment. Th e course of the current pregnancy was 
otherwise normal and microbiological cervical swabs 
were negative for pathogens. From the family history it 
was noted that her father had died from myocardial 
infarction, but her mother was healthy. Personal his-
tory was unremarkable; she works as a trader, denied 
drug use, and smoked 10 cigarettes per day prior to 
pregnancy. On admission, regular vital functions were 
recorded including normal temperature, pulse, and 
blood pressure. Laboratory tests (hematologic, coagu-
lation, biochemical including C-reactive protein) were 
within the reference range. Obstetric examination 
evaluated patency of the cervical canal to 2 cm. Ultra-
sound confi rmed the initial diagnosis.
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Given the fi ndings, the patient was explained the 
possible risks of therapy and consent was obtained for 
the induction of labor with a 0.25 mg intramuscular 
dose of the prostaglandin carboprost thromethamine 
(Prostin 15 M®, Pfi zer). Antibiotic prophylaxis was 
achieved with ampicillin intravenous 1 g/6 h. Half an 
hour after the fi rst injection of carboprost, the patient 
was cold, sweaty, weak, and felt urgent need to defecate.
With the help of a midwife, she went to the toilet 
but collapsed. Th e midwife could not palpate the pulse, 
and she lied the patient on the fl oor, put her in Tren-
delenburg’s position, and called a doctor. Upon arrival, 
the doctor palpated pulse of 35/min on radial artery. Th e 
patient was somnolent, complaining of painless discom-
fort in the chest. Her vital parameters showed oxygen 
saturation of 90% and blood pressure of 90/50 mm Hg.
Immediate intravenous infusion of Ringer’s lactate 
was administered, but she was still bradycardic. After 5 
minutes, a 0.5 mg dose of atropine was administered 
intravenously, successfully raising the pulse to 50/min. 
Th e elevation in heart rate was only transient, as it 
dropped soon to 30/min. Th e patient was administered 
500 mL of colloid solution (HAES) and transferred to 
the Intensive Care Unit (ICU). In the ICU, her blood 
pressure was 100/60 mm Hg and her electrocardio-
gram (ECG) showed sinus bradycardia of 30/min. No 
other abnormalities, including abnormal atrioventric-
ular conduction, were detected on ECG. Another 0.5 
mg dose of atropine was administered intravenously. 
Th e possible embolic events and acute coronary syn-
drome were excluded by laboratory analysis of D-di-
mer, troponin and creatine phosphokinase (MB frac-
tion). One hour after arrival, repeat ECG still showed 
sinus bradycardia without any eff ect of three repeated 
0.5 mg doses of intravenous atropine. Blood pressure 
was maintained at 110/70 mm Hg with the adminis-
tration of colloids and crystalloids.
While in the ICU, the pregnant patient felt strong 
contractions and quickly delivered a dead embryo with 
the placenta en bloc. Ultrasound showed a blank empty 
uterine cavity and obstetric procedure ended. Prophy-
lactic use of ampicillin was continued. Half an hour 
after delivery, a heart rate increase to 50/min was not-
ed, and then to 60/min after one hour. Follow up labo-
ratory fi ndings were normal, except for mild leukocy-
tosis to 12.3 (the possible side eff ect of prostaglandin). 
With continuous monitoring, the patient had no more 
episodes of bradycardia or hypotension. After 24-hour 
continuous ECG recording and echocardiographic ex-
amination, both of which were unremarkable, she was 
discharged with recommendation to do clinical ex-
amination after one month. Follow up cardiologist ex-
amination performed one month later showed normal 
cardiac status.
Discussion
Th e eff ects of prostaglandins on the cardiovascular 
system are rare, but can be dramatic. Bradycardia and 
hypotension caused by exogenous prostaglandin was 
described in experimental pharmacology (e.g., on cats), 
and the mentioned complications were inhibited by 
use of meclofenamic acid4. Hainsworth5 has described 
the possible pathophysiological mechanism of brady-
cardia and hypotension on endogenous bradykinin 
and prostaglandins due to the eff ects on chemosensi-
tive ventricular mechanoreceptors and coronary baro-
receptors. Hintze6 has described vasoactive eff ects of 
prostaglandin with refl ex bradycardia and hypotension 
due to stimulation of cardiac receptors predominantly 
in the inferoposterior wall of the left ventricle.
Vagal bradycardia as an eff ect of prostaglandins 
due to activation of cardiac refl ex sensitivity to myo-
cardial ischemia has been described by Staszewska-
Barczak7. However, only a few papers describe the 
negative cardiovascular eff ects of prostaglandins in ob-
stetrics. Vasospastic angina pectoris with bradycardia 
after induction of labor with mifepristone and ge-
meprost in pregnant women with migraine and smok-
ing history has been described by Lindhardt et al.1. Th e 
authors suggest taking careful history of the possible 
vasospastic disease in women as the prevention of seri-
ous cardiac complications.
Two works report on cardiac arrest after adminis-
tration of sulprostone. In the fi rst one, arrest occurred 
upon the intravenous use of sulprostone after cesarean 
section due to postpartum hemorrhage with successful 
resuscitation. Th e authors emphasize the potential im-
pact of sulprostone on coronary spasm, bradycardia, 
and asystole2. Th e other describes cardiac arrest in a 
39-year-old woman in labor after the application of 
sulprostone into the uterine cavity because of postpar-
tum hemorrhage following manual removal of the pla-
centa. Resuscitation took a long time, but was success-
ful. Evidence in the literature suggests that sulprostone 
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is contraindicated in women who are older than 35 
years, smoke, or have other cardiovascular risk factors3.
With the exception of smoking outside of preg-
nancy, our patient had no major risk factors for devel-
oping cardiovascular side eff ects. Considering that the 
patient’s sinus rhythm spontaneously normalized as 
carboprost was eliminated from the body (it has a 
3-hour half-life), it is reasonable to believe that the 
specifi c prostaglandin underlay the etiology of brady-
cardia.
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Sažetak
REFRAKTORNA BRADIKARDIJA – RIJETKA KOMPLIKACIJA KARBOPROST TROMETAMINA 
ZA INDUCIRANJE POBAČAJA
J. Čerkez Habek, D. Habek i D. Gulin
Autori prikazuju prvi slučaj refraktorne višesatne sinusne bradikardije, rijetke komplikacije intramuskularne aplikacije 
karboprost trometamina za induciranje pobačaja iz medicinske indikacije u bolesnice bez srčanožilnih i ostalih bolesti.  Nakon 
davanja 3x0,5 mg atropin sulfata intravenski učinak je izostao, no ritam se spontano normalizirao u sinusni nakon tri sata, što 
se može smatrati kao vrijeme poluraspada prostaglandina i njegova rijetkog učinka na srčanožilni sustav.
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